IFNG and colitis: As shown in Figure 5C, DSS-induced colitis markedly increased the production of IFN-γ (309.23 ± 122.83 pg/mL) in colonic tissue, while the production was suppressed upon ASB treatments with high, medium and low dosage (235.22 ± 91.03 pg/mL, 219.13 ± 79.14 pg/mL, 219.52 ± 72.98 pg/mL, respectively).